Related Experiment Video
Updated: May 25, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin syndrome associated with MDPV use: a case report.
Josh Mugele1, Kristine A Nañagas, Laura M Tormoehlen
1Indiana University School of Medicine, Indianapolis, IN, USA. jmugele@iupui.edu
This case study highlights a patient who developed serotonin syndrome after using 3,4-methylenedioxypyrovalerone (MDPV), a synthetic drug. Treatment involved cyproheptadine and supportive care for symptom resolution.
Area of Science:
- Toxicology
- Pharmacology
- Clinical Medicine
Background:
- Serotonin syndrome is a potentially life-threatening condition linked to serotonergic drug use.
- Commonly implicated substances include amphetamines, cocaine, and ecstasy.
- Synthetic cathinones, like MDPV, are increasingly recognized as potential causes.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Toxidromes: Clinical Features
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
